Safety and Pharmacokinetics of Recombinant Anti-EGFr Antibody in Patients With Metastatic Colorectal Cancer
Clinical trial NCT03017807 · COMPLETED
Trial details
- NCT number
- NCT03017807
- Sponsor
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-30
- Primary completion
- 2018-01-22
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.